Alzheimer Disease Clinical Trials in Jacksonville, Florida

4 studies are recruiting for alzheimer disease in Jacksonville, Florida right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease

    The objective of this investigational device exemption (IDE) study is to evaluate the safety and feasibility of using the Symani System and microsurgical techniques in the deep cervical lymph node (dCLN) region in the setting of mild to moderate Alzheimer's disease and lymphatic abnormalities.

    Stage
    Not phased
    Ages
    50 and older
    Site
    Baptist Health Research Institute, Jacksonville, Florida
    Locations
    3 in total
    Run by
    MMI (Medical Microinstruments, Inc.)
  2. A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

    The main purpose of this study is to determine if participants who previously took donanemab get clinical benefit when they receive annual doses. For each participant, the study will last up to 2.5 years and will include 6 visits.

    Stage
    Phase 3
    Ages
    55 and older
    Site
    Jacksonville Center for Clinical Research, Jacksonville, Florida
    Locations
    59 in total
    Run by
    Eli Lilly and Company
  3. [18F]PI-2620 Phase 3 Histopathological Study

    This study is an open-label, multi-center, non-randomized pivotal Phase 3 study to assess the efficacy and safety of PET imaging with [18F]PI-2620 for detection of tau deposition in subjects with Alzheimer's disease (AD) and controls during lifetime when compared to histopathology obtained after de…

    Stage
    Phase 3
    Ages
    50 and older
    Site
    UF College of Medicine - Jacksonville, Jacksonville, Florida
    Locations
    25 in total
    Run by
    Lantheus Biosciences Ltd.
  4. Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease

    The researchers are trying to determine whether ovarian hormones are associated with aging processes and with the risk of developing Alzheimer's disease in women.

    Stage
    Phase 4
    Ages
    60 and older
    Site
    Mayo Clinic, Jacksonville, Florida
    Locations
    2 in total
    Run by
    Mayo Clinic

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.